This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bedell, M A Articles by Laimins, L A Search for Related Content PubMed PubMed Citation Articles by Bedell, M A Articles by Laimins, L A

 Previous Article  |  Next Article 

J Virol. 1987 November; 61(11): 3635-3640

The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells.

Department of Molecular Genetics and Cell Biology, University of Chicago, Illinois 60637.

ABSTRACT

Plasmids containing the E6 and E7 open reading frames of human papillomavirus type 18 expressed from an autologous transcriptional control region were sufficient for transformation of NIH 3T3 and Rat-1 cells. Transformation by these sequences did not always involve morphological alterations even though anchorage-independent growth occurred at a high frequency. In these cells, the efficiency of transformation by the E6 and E7 construct was equivalent to or, in most cases, better than that observed with the entire viral genome. These data indicate that a major human papillomavirus type 18 transforming function is localized in either the E6 or E7 gene products or both.

This article has been cited by other articles:

• Tungteakkhun, S. S., Filippova, M., Neidigh, J. W., Fodor, N., Duerksen-Hughes, P. J. (2008). The Interaction between Human Papillomavirus Type 16 and FADD Is Mediated by a Novel E6 Binding Domain. J. Virol. 82: 9600-9614 [Abstract] [Full Text]  
• Liu, X., Clements, A., Zhao, K., Marmorstein, R. (2006). Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor. J. Biol. Chem. 281: 578-586 [Abstract] [Full Text]  
• Lagrange, M., Charbonnier, S., Orfanoudakis, G., Robinson, P., Zanier, K., Masson, M., Lutz, Y., Trave, G., Weiss, E., Deryckere, F. (2005). Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6. J. Gen. Virol. 86: 1001-1007 [Abstract] [Full Text]  
• Bermudez-Humaran, L. G., Cortes-Perez, N. G., Le Loir, Y., Alcocer-Gonzalez, J. M., Tamez-Guerra, R. S., de Oca-Luna, R. M., Langella, P. (2004). An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol 53: 427-433 [Abstract] [Full Text]  
• Degenhardt, Y. Y., Silverstein, S. (2001). Interaction of Zyxin, a Focal Adhesion Protein, with the E6 Protein from Human Papillomavirus Type 6 Results in Its Nuclear Translocation. J. Virol. 75: 11791-11802 [Abstract] [Full Text]  
• Janicek, M. F., Averette, H. E. (2001). Cervical Cancer: Prevention, Diagnosis, and Therapeutics. CA Cancer J Clin 51: 92-114 [Abstract] [Full Text]  
• Stoppler, H., Hartmann, D.-P., Sherman, L., Schlegel, R. (1997). The Human Papillomavirus Type 16 E6 and E7 Oncoproteins Dissociate Cellular Telomerase Activity from the Maintenance of Telomere Length. J. Biol. Chem. 272: 13332-13337 [Abstract] [Full Text]